In all three brands of MenACWY, the most common adverse events were injection site pain, swelling or redness. Other reported symptoms included malaise and headache.
Ask the Experts: Meningococcal ACWY: Vaccine Safety
Yes. The National Vaccine Injury Compensation Program includes payment for injuries determined to have occurred following vaccination with a vaccine routinely recommended for children in the United States. The recipient can be of any age, but the vaccine must be routinely recommended for children and teens through age 18 years. MenACWY is routinely recommended for children so it is included in the program. More information about the program and the covered vaccines is at www.hrsa.gov/vaccine-compensation/covered-vaccines/index.html.